Millennium Management’s BIND THERAPEUTICS INC BIND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-32,451
Closed -$13K 3913
2016
Q2
$13K Buy
+32,451
New +$26.6K ﹤0.01% 3110
2015
Q4
Sell
-24,500
Closed -$109K 4104
2015
Q3
$109K Buy
24,500
+5,700
+30% +$28K ﹤0.01% 3259
2015
Q2
$105K Buy
18,800
+7,313
+64% +$45.3K ﹤0.01% 3159
2015
Q1
$63K Sell
11,487
-18,196
-61% -$112K ﹤0.01% 3450
2014
Q4
$160K Sell
29,683
-28,009
-49% -$210K ﹤0.01% 3698
2014
Q3
$496K Sell
57,692
-297
-0.5% -$2.93K ﹤0.01% 2752
2014
Q2
$764K Sell
57,989
-57,204
-50% -$560K ﹤0.01% 2348
2014
Q1
$1.38M Buy
115,193
+42,698
+59% +$558K ﹤0.01% 2036
2013
Q4
$1.09M Buy
+72,495
New +$922K ﹤0.01% 2220

Millennium Management's BIND Position: Q3 2016 in Review

Millennium Management sold out of BIND THERAPEUTICS INC (BIND) in Q3 2016, closing a stake of 32,451 shares — an estimated $13K sold.

Millennium Management first reported a position in BIND in Q4 2013 and held it in 9 quarters. The position peaked at $1.38M in Q1 2014. 0 funds tracked by Wall St. Rank hold BIND as of Q3 2016.

  • Millennium Management reported no remaining BIND THERAPEUTICS INC position as of Q3 2016 after selling out during the quarter.
  • Millennium Management sold 32,451 BIND THERAPEUTICS INC shares in Q3 2016, an estimated $13K.
  • Millennium Management first reported a position in BIND THERAPEUTICS INC in Q4 2013 and held it in 9 quarters.
  • Millennium Management's BIND THERAPEUTICS INC position peaked at $1.38M in Q1 2014.
  • 0 funds tracked by Wall St. Rank held BIND THERAPEUTICS INC as of Q3 2016.

Based on Millennium Management's 13F filing for Q3 2016, filed 14 Nov 2016.